Detalhe da pesquisa
1.
Dapagliflozin effect on endothelial dysfunction in diabetic patients with atherosclerotic disease: a randomized active-controlled trial.
Cardiovasc Diabetol
; 20(1): 74, 2021 03 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-33771149
2.
Adiponectin concentration data improve the estimation of atherosclerotic risk in normal and in overweight subjects.
Clin Endocrinol (Oxf)
; 88(3): 388-396, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29280189
3.
Validation of surrogate indexes of insulin sensitivity in acute phase of myocardial infarction based on euglycemic-hyperinsulinemic clamp.
Am J Physiol Endocrinol Metab
; 306(4): E399-403, 2014 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24347056
4.
Glucose-lowering Drugs and Hospitalization for Heart Failure: A Systematic Review and Additive-effects Network Meta-analysis With More Than 500 000 Patient-years.
J Clin Endocrinol Metab
; 106(10): 3060-3067, 2021 09 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-34125217
5.
Dapagliflozin increases the lean-to total mass ratio in type 2 diabetes mellitus.
Nutr Diabetes
; 11(1): 17, 2021 06 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34120150
6.
Dapagliflozin increases retinal thickness in type 2 diabetic patients as compared with glibenclamide: A randomized controlled trial.
Diabetes Metab
; 47(6): 101280, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34537385
7.
Inhibition of the sodium-glucose co-transporter 2 in the elderly: clinical and mechanistic insights into safety and efficacy.
Rev Assoc Med Bras (1992)
; 65(1): 70-86, 2019 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-30758423
8.
Central role of obesity in endothelial cell dysfunction and cardiovascular risk.
Rev Assoc Med Bras (1992)
; 65(1): 87-97, 2019 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-30758424
9.
Effect of pioglitazone treatment on brown adipose tissue volume and activity and hypothalamic gliosis in patients with type 2 diabetes mellitus: a proof-of-concept study.
Acta Diabetol
; 56(12): 1333-1339, 2019 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-31506721
10.
Statin Short-term Inhibition of Insulin Sensitivity and Secretion During Acute Phase of ST-Elevation Myocardial Infarction.
Sci Rep
; 9(1): 16401, 2019 11 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31704948
11.
Assessment of dapagliflozin effect on diabetic endothelial dysfunction of brachial artery (ADDENDA-BHS2 trial): rationale, design, and baseline characteristics of a randomized controlled trial.
Diabetol Metab Syndr
; 11: 62, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31384310
12.
Adverse outcome has a U-shaped relation with acute phase change in insulin sensitivity after ST-Elevation Myocardial Infarction.
Int J Cardiol
; 254: 16-22, 2018 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29246426
13.
Dapagliflozin reduces adiposity and increases adiponectin in patients with type 2 diabetes and atherosclerotic disease at short-term: An active-controlled randomised trial.
Diabetes Metab
; 48(2): 101304, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34808345
14.
TCF7L2 polymorphism is associated with low nitric oxide release, endothelial dysfunction and enhanced inflammatory response after myocardial infarction.
BBA Clin
; 5: 159-65, 2016 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-27213136
15.
Glycosylated hemoglobin is associated with decreased endothelial function, high inflammatory response, and adverse clinical outcome in non-diabetic STEMI patients.
Atherosclerosis
; 243(1): 124-30, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26385505
16.
Central role of obesity in endothelial cell dysfunction and cardiovascular risk
Rev. Assoc. Med. Bras. (1992)
; 65(1): 87-97, Jan. 2019. graf
Artigo
em Inglês
| LILACS | ID: biblio-985008
17.
Inhibition of the sodium-glucose co-transporter 2 in the elderly: clinical and mechanistic insights into safety and efficacy
Rev. Assoc. Med. Bras. (1992)
; 65(1): 70-86, Jan. 2019. tab, graf
Artigo
em Inglês
| LILACS | ID: biblio-985001
18.
High-density lipoprotein levels are strongly associated with the recovery rate of insulin sensitivity during the acute phase of myocardial infarction: a study by euglycemic hyperinsulinemic clamp.
J Clin Lipidol
; 7(1): 24-8, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23351579
19.
High plasma HDL-C attenuates stress hyperglycemia during acute phase of myocardial infarction.
Atherosclerosis
; 220(1): 231-6, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22018645
20.
Rebound inflammatory response during the acute phase of myocardial infarction after simvastatin withdrawal.
Atherosclerosis
; 207(1): 191-4, 2009 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-19464010